DKA
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Diabetic Ketoacidosis From New SGLT2i: Can Genomics Estimate Risk (NCT05402579) | Mount Sinai Hospital, Canada | 2022-07-29 |
| Early Administration of Insulin Glargine in Patients With Diabetic Ketoacidosis (NCT06007508) | HealthPartners Institute | 2022-05-31 |
Track DKA automatically
Every clearance here is in the API, with alerts when new ones post.